Download full-text PDF

Source
http://dx.doi.org/10.1016/j.joms.2009.08.005DOI Listing

Publication Analysis

Top Keywords

bisphosphonate-induced osteonecrosis
4
osteonecrosis jaw
4
jaw months
4
months interruption
4
interruption zoledronate
4
zoledronate patient
4
patient multiple
4
multiple myeloma
4
bisphosphonate-induced
1
jaw
1

Similar Publications

Targeting endoplasmic reticulum stress-induced lymphatic dysfunction for mitigating bisphosphonate-related osteonecrosis.

Clin Transl Med

November 2024

Department of Oral and Maxillofacial Surgery, The Affiliated Hospital of Stomatology, Nanjing Medical University, Nanjing, China.

Background: Bisphosphonates (BPs) are the first-line treatment to stop bone resorption in diseases, including osteoporosis, Paget's disease, multiple myeloma and bone metastases of cancer. However, BPs-related osteonecrosis of the jaw (BRONJ), characterized by local inflammation and jawbone necrosis, is a severe intractable complication. The cumulative inflammatory burden often accompanies impaired lymphatic drainage, but its specific impact on BRONJ and the underlying mechanisms remain unclear.

View Article and Find Full Text PDF

The Potential of Enamel Matrix Derivative in Countering Bisphosphonate-Induced Effects in Osteoblasts.

Life (Basel)

August 2024

Department of Oral & Maxillofacial Surgery, Kyung Hee University College of Dentistry, Kyung Hee University Medical Center, Seoul 02447, Republic of Korea.

The suppressive effect of bisphosphonates (BPs) on bone metabolism is considered to be a major cause of medication-related osteonecrosis of the jaw (MRONJ). Enamel matrix derivative (EMD) stimulates and activates growth factors, leading to the regeneration of periodontal tissues. In this study, we aimed to explore the potential of EMD in reversing the detrimental effects of BPs on human fetal osteoblasts (hFOBs) and osteosarcoma-derived immature osteoblasts (MG63s) by assessing cell viability, apoptosis, migration, gene expression, and protein synthesis.

View Article and Find Full Text PDF

External Auditory Canal Erosion at the 6 O'clock Spot.

Otol Neurotol

September 2024

Department of Otolaryngology-Head and Neck Surgery, University of Illinois Chicago, Chicago, Illinois.

Article Synopsis
  • - The study identifies a common site of erosion in the external ear canal, specifically at the "6 o'clock" position, which is frequently observed among various ear pathologies.
  • - Eight otology patients treated in 2023 exhibited erosion at this specific location, with findings indicating that other erosions rarely occur elsewhere in the canal.
  • - The results suggest that this "6 o'clock spot" may play a significant role in conditions like keratosis obturans and necrotizing otitis externa, highlighting its importance in ear health monitoring.
View Article and Find Full Text PDF

Osteonecrosis of the jaw (ONJ) is a relatively rare side effect after prolonged use of bisphosphonates, which are drugs used to treat bone resorption in osteoporosis and certain cancers. This study introduces a novel ONJ model in rats by combining exposure to bisphosphonates, oral surgery, and bacterial inoculation. Potential ONJ preventive effects of polyguanidine (GuaDex) or antibiotics were evaluated.

View Article and Find Full Text PDF

Role of sclerostin deletion in bisphosphonate-induced osteonecrosis of the jaw.

Bone

October 2024

Department of Periodontal Medicine, Graduate School of Biomedical and Health Sciences, Hiroshima University, Japan.

Purpose: Bone resorption inhibitors, such as bisphosphonates (BP) and denosumab, are frequently used for the management of osteoporosis. Although both drugs reduce the risk of osteoporotic fractures, they are associated with a serious side effect known as medication-related osteonecrosis of the jaw (MRONJ). Sclerostin antibodies (romosozumab) increase bone formation and decrease the risk of osteoporotic fractures: however, their anti-resorptive effect increases ONJ.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!